Tokuda Yasuharu, Kashima Masayuki, Kayo Mami, Nakazato Nobuhiko, Stein Gerald H
Department of Medicine, St. Luke's International Hospital, 10-1 Akashi-cho, Chuo-ku, Tokyo 104-0044, Japan.
Intern Med. 2006;45(19):1079-85. doi: 10.2169/internalmedicine.45.1525. Epub 2006 Nov 1.
Because of an increasing number of case reports of copper deficiency associated with long-term tube feeding nutrition in Japan, we identified patients with copper deficiency associated with long-term tube feeding and described the prevalence, clinical data and cocoa treatment for these patients.
We conducted a retrospective study to identify patients who were referred from long-term care institutions and had copper deficiency associated with tube feeding. We reviewed all serum copper concentration data during a 6-year period. We also compared admission and post-treatment peripheral blood counts.
Among 210 consecutive admissions with nutritional tube feeding from long-term care institutions (N=210), we identified 13 (6.2%) patients with copper deficiency (aged 46-91; 12 women). All patients had anemia, while most had neutropenia. The range of serum copper concentrations of these patients was 0.1-2.4 microg/L (normal; 6.8-12.8 microg/L). Their feeding formulas revealed a low copper content (5 to 12 microg per 100 kcal of each formula). Cocoa powder was used as the treatment. With cocoa supplements, the blood leukocyte count and hemoglobin significantly improved in all patients. Median leukocyte counts were 1,800 /mm(3)at admission and 6,300/mm(3) at follow-up (p=0.001). Median hemoglobin were 7.0 g/dl at admission and 10.3 g/dl at follow-up (p=0.001). Two patients developed transient tachycardia as a possible adverse effect of cocoa.
We identified many cases with copper deficiency associated with tube feeding in Okinawa, Japan. Cocoa supplement appeared to be a safe and effective treatment. Increasing the copper content of Japanese tube feeding formulas should be considered for its prevention.
由于日本长期管饲营养相关铜缺乏的病例报告数量不断增加,我们确定了长期管饲相关铜缺乏患者,并描述了这些患者的患病率、临床数据及可可治疗情况。
我们进行了一项回顾性研究,以确定从长期护理机构转诊且患有管饲相关铜缺乏的患者。我们回顾了6年期间的所有血清铜浓度数据。我们还比较了入院时和治疗后的外周血细胞计数。
在210例来自长期护理机构的连续营养管饲入院患者(N = 210)中,我们确定了13例(6.2%)铜缺乏患者(年龄46 - 91岁;12名女性)。所有患者均有贫血,多数患者有中性粒细胞减少。这些患者的血清铜浓度范围为0.1 - 2.4微克/升(正常范围为6.8 - 12.8微克/升)。他们的喂养配方显示铜含量低(每种配方每100千卡含5至12微克铜)。使用可可粉进行治疗。补充可可后,所有患者的血液白细胞计数和血红蛋白均显著改善。入院时白细胞计数中位数为1800/mm³,随访时为6300/mm³(p = 0.001)。入院时血红蛋白中位数为7.0克/分升,随访时为10.3克/分升(p = 0.001)。两名患者出现短暂性心动过速,可能是可可的不良反应。
我们在日本冲绳确定了许多与管饲相关的铜缺乏病例。可可补充剂似乎是一种安全有效的治疗方法。为预防起见,应考虑提高日本管饲配方中的铜含量。